What pharma and biotech professionals need to know about the Drug Supply Chain Security Act and new track-and-trace regulations. Full articl

The entrance of cell and gene therapies into the market is impacting every corner of the industry. Likewise, the demand for high-quality CG

It’s crucial to appreciate the complexities of global pricing and contracting so that you can prepare the smartest approach. Understanding

With the right approach, a good team, and a realistic timeline, pharma companies can successfully support their patients in new and exciting

Creating a great customer experience for your product relies on accurate data. New Archbow team member, Sarah Feldmann, simplifies the overw

While many large pharma companies – based in the U.S. or elsewhere – have teams dedicated to maximizing revenue opportunities worldwide, the

Before saying goodbye to 2018, we took a quick look back at how well we, and the industry, anticipated and prepared for the trends that shap

The IPI could entirely reshape the way pharma thinks about their business model in the U.S. Archbow's international pricing expert answe

Anyone working in oncology needs to be up to speed on these 10 takeaways from the 2018 ABVCC Summit - from the International Pricing Index t

We formed the company because we thought we could apply our diverse real-world experience and deep industry connections in a way that would

Archbow Consulting teamed up with Pharmaceutical Executive in their September 2018 issue to explore how to overcome the fundamental complexi

Copay accumulator solutions aren’t something you can buy off a shelf because customized, negotiated, collaborative approaches are the only s

Tami Stowe has been operationalizing pharma access programs for more than 18 years. Because her career has evolved alongside our industry&#3

Finding the best pharma consultant can be a challenge. Follow these three steps to select a consulting partner that is the right fit, right

If gene therapies, digitalization, and copay accumulators are top of mind concerns, you're not alone. Read our takeaways on these pressi

In the wake of copay accumulator growth, pharma companies may be forced to shoulder increased spending to help patients stay on therapy. Six

New Archbow team member, Justine Hughes, shares five priceless lessons she's learned while managing the frontlines of pharma patient acc

Archbow Consulting worked with Pharmaceutical Executive to highlight ten pharma and biotech trends worth watching in 2018. Everything from t

Archbow Consulting is a new company, yet you may already know us. We’ve worked in many roles across the industry – from pharma companies ...